bf/NASDAQ:NVNO_icon.png

NASDAQ:NVNO

enVVeno Medical Corporation

  • Stock

USD

Last Close

0.66

06/11 21:56

Market Cap

77.85M

Beta: 1.25

Volume Today

108.72K

Avg: 25.60K

PE Ratio

−2.05

PFCF: −3.12

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-1.60M
-
-3.39M
111.19%
-7.79M
130.01%
-13.04M
67.40%
-7.63M
41.54%
-9.14M
19.80%
-16.53M
80.92%
-24.67M
49.26%
-23.52M
4.67%
depreciation and amortization
125.42K
-
151.17K
20.53%
139.21K
7.91%
133.42K
4.16%
396.67K
197.31%
383.97K
3.20%
452.91K
17.95%
525K
15.92%
546K
4%
deferred income tax
871.18K
-
-231.41K
126.56%
-1.35M
484.81%
588.82K
143.51%
-184.00K
131.25%
-312.70K
69.94%
221K
-
stock based compensation
1.51M
-
878.40K
41.84%
1.92M
118.86%
941.96K
51.00%
881.21K
6.45%
6.00M
580.79%
8.99M
49.92%
5.20M
42.23%
change in working capital
-540.70K
-
269.31K
149.81%
1.09M
305.81%
-578.40K
152.92%
66.79K
111.55%
665.78K
896.86%
-1.14M
271.95%
-130K
88.64%
-616K
373.85%
accounts receivables
25.24K
-
309K
1,124.25%
-11.68K
103.78%
3.16K
127.04%
32.02K
913.68%
inventory
171.90K
-
-213.18K
224.01%
90.91K
142.64%
-217.04K
338.74%
accounts payables
-83.54K
-
-76.32K
8.64%
545.38K
814.58%
-294.12K
153.93%
144.07K
148.98%
169.17K
17.43%
-832.70K
592.22%
88K
110.57%
-221K
351.14%
other working capital
-654.30K
-
249.81K
138.18%
468.28K
87.46%
-70.40K
115.03%
-109.30K
55.26%
496.61K
554.35%
-312.10K
162.85%
-218K
30.15%
-395K
81.19%
other non cash items
-177
-
-2.50M
1,411,794.92%
1.71M
168.43%
6.56M
283.76%
-265.24K
104.04%
-288.69K
8.84%
-312.61K
8.29%
-339K
8.44%
-689K
103.24%
net cash provided by operating activities
-2.02M
-
-3.08M
52.75%
-4.20M
36.23%
-6.36M
51.25%
-5.90M
7.23%
-7.68M
30.20%
-11.85M
54.30%
-15.62M
31.85%
-18.86M
20.74%
investments in property plant and equipment
-2.62K
-
-373.62K
14,160.15%
-10.94K
97.07%
-12.42K
13.57%
-363.89K
2,829.41%
-180.29K
50.45%
-367.89K
104.05%
-115K
68.74%
-33K
71.30%
acquisitions net
34.44K
-
purchases of investments
-48.13M
-
-56.52M
17.44%
sales maturities of investments
13.69M
-
48.69M
255.68%
other investing activites
-75K
-
-331.65K
342.20%
176.25K
153.14%
-34.44K
-
net cash used for investing activites
-77.62K
-
-705.27K
808.61%
165.31K
123.44%
-12.42K
107.51%
-363.89K
2,829.41%
-180.29K
50.45%
-367.89K
104.05%
-34.55M
9,292.48%
-7.87M
77.23%
debt repayment
-612K
-
-186.62K
69.51%
-174.73K
6.37%
-1.25M
613.01%
-312.70K
-
common stock issued
7.66M
-
5.64M
26.39%
10.42M
84.82%
57.36M
450.59%
25.79M
-
common stock repurchased
dividends paid
other financing activites
4.24M
-
2.45M
42.22%
4.23M
72.92%
2.62M
38.11%
5.64K
99.78%
4.97M
88,055.35%
245.25K
95.06%
net cash used provided by financing activities
3.62M
-
2.26M
37.61%
4.06M
79.46%
9.03M
122.55%
5.64M
37.58%
15.07M
167.43%
57.61M
282.14%
25.79M
-
effect of forex changes on cash
net change in cash
1.53M
-
-1.53M
200.10%
21.17K
101.39%
2.66M
12,476.54%
-623.36K
123.41%
7.22M
1,257.81%
45.39M
528.95%
-50.17M
210.53%
-935K
98.14%
cash at beginning of period
58.03K
-
1.59M
2,631.89%
56.51K
96.43%
77.69K
37.47%
2.74M
3,427.76%
2.12M
22.74%
9.33M
340.87%
54.73M
486.29%
4.55M
91.68%
cash at end of period
1.59M
-
56.51K
96.43%
77.69K
37.47%
2.74M
3,427.76%
2.12M
22.74%
9.33M
340.87%
54.73M
486.29%
4.55M
91.68%
3.62M
20.53%
operating cash flow
-2.02M
-
-3.08M
52.75%
-4.20M
36.23%
-6.36M
51.25%
-5.90M
7.23%
-7.68M
30.20%
-11.85M
54.30%
-15.62M
31.85%
-18.86M
20.74%
capital expenditure
-2.62K
-
-373.62K
14,160.15%
-10.94K
97.07%
-12.42K
13.57%
-363.89K
2,829.41%
-180.29K
50.45%
-367.89K
104.05%
-115K
68.74%
-33K
71.30%
free cash flow
-2.02M
-
-3.46M
71.03%
-4.21M
21.83%
-6.37M
51.15%
-6.26M
1.70%
-7.86M
25.51%
-12.21M
55.44%
-15.73M
28.82%
-18.89M
20.06%

All numbers in USD (except ratios and percentages)